Sort
39,280 grants matching “leukemia”
Targeted therapy of ALL with gene-modified central memory T cells
$542,633Stanley R Riddell · Fred Hutchinson Cancer Research Center · R01 · FY2012 · CA
CCR-Frederick Flow Cytometry Core
$542,585Jeffrey Carrell · Division Of Basic Sciences - Nci · ZIC · FY2025 · CA
Chromatin assembly and formaldehyde toxicity
$542,557Chunyuan Jin · New York University School Of Medicine · R01 · FY2023 · ES
Targeting Alloreactivity for Leukemia Eradication
$542,432Stanley R Riddell · Fred Hutchinson Cancer Research Center · P01 · FY2010 · CA
Targeting Novel Pathways in JMML
$542,416Reuben Kapur · Indiana University Indianapolis · R01 · FY2022 · HL
Targeting Novel Pathways in JMML
$542,416Reuben Kapur · Indiana University Indianapolis · R01 · FY2021 · HL
JHU- Optimal regimen development on a Ribosome inhibitor backbone.
$542,407Eric L Nuermberger · Global Alliance For Tb Drug Development · U19 · FY2021 · AI
Genetic Loss-of-Function Studies of SETD2 in Kidney Tumorigenesis
$542,407Emily H Cheng · Sloan-Kettering Inst Can Research · R01 · FY2021 · CA
Small molecule probes of MYC stability and function intumorigenesis
$542,383Sarki A. Abdulkadir · Northwestern University At Chicago · R01 · FY2024 · CA
Project 2: Molecular Modulation of Chromatin and Nuclear Structure in Cancer
$542,300Jonathan D. Licht · Northwestern University At Chicago · U54 · FY2016 · CA
Unraveling the Pathophysiology of Neurotoxicity Induced by CAR T-cells
$542,294Christopher A Pennell · University Of Minnesota · R01 · FY2025 · CA
Unraveling the Pathophysiology of Neurotoxicity Induced by CAR T-cells
$542,294Christopher A Pennell · University Of Minnesota · R01 · FY2022 · CA
Artificial, Humanized Stem Cell Niches
$542,171Biju Parekkadan · Rutgers, The State Univ Of N.J. · R01 · FY2021 · EB
Clinical Trial of Ceramide nanoLiposomes in AML
$542,148Charles E Chalfant · University Of Virginia · P01 · FY2024 · CA
Targeting medium chain fatty acid metabolism for the treatment of chronic Graft-versus-Host Disease
$542,119Hung Nguyen · University Of Central Florida · R01 · FY2024 · HL
Targeting FTO to treat acute myeloid leukemia
$542,055Jianjun Chen · Beckman Research Institute/City Of Hope · R01 · FY2024 · CA
The genomic pathogenesis of Follicular Lymphoma
$541,994Sami Nimer Malek · University Of Michigan At Ann Arbor · R01 · FY2017 · CA
The genomic pathogenesis of Follicular Lymphoma
$541,994Sami Nimer Malek · University Of Michigan At Ann Arbor · R01 · FY2016 · CA
Humanized bone marrow-like model to study patient-derived myeloma xenografts
$541,945Constantine S. Mitsiades · Dana-Farber Cancer Inst · R01 · FY2017 · CA
New control of oncogene activation in T-cell leukemia
$541,927Chengyu Liang · Wistar Institute · R01 · FY2022 · CA
Molecular Genetics of CLL
$541,785Carlo M Croce · University Of California, San Diego · P01 · FY2007 · CA
Targeting RET in Lung Cancer
$541,784Pasi A Janne · Dana-Farber Cancer Inst · R01 · FY2016 · CA
Targeting RET in Lung Cancer
$541,784Pasi A Janne · Dana-Farber Cancer Inst · R01 · FY2015 · CA
Targeting RET in Lung Cancer
$541,784Pasi A Janne · Dana-Farber Cancer Inst · R01 · FY2017 · CA
Targeting RET in Lung Cancer
$541,784Pasi A Janne · Dana-Farber Cancer Inst · R01 · FY2013 · CA